EXEL
EXEL
NASDAQ · Biotechnology

Exelixis Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$51.52
+0.17 (+0.33%)
As of Jun 23, 7:55 PM ET ·
Analyst Consensus
Buy
26
Analysts
High
Coverage
Buy 15 58%
Hold 10 38%
Sell 1 4%
Price Target
Analyst Price Target +125.3% upside
Low Target $78.53
Average Target $116.10
High Target $123.77
Current Price $51.52
Current
$51.52
Target
$116.10
$78.53 $116.10 avg $123.77
Scenario Analysis
Bear Case
$78.53
52.4%
Low target
Base Case
$116.10
+125.3%
Avg target
Bull Case
$123.77
+140.2%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$53.93
-4.5% from high
52-Week Low
$33.76
+52.6% from low
50-Day SMA
$43.59
+18.2% vs SMA
200-Day SMA
$41.49
+24.2% vs SMA
RSI (14)
62.0
Neutral
Target vs 52W High
$116.10
+115.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +10.2%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +188.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.6%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%